Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
Seventeen patients with hypertension and osteoarthritis participated in a single-blind crossover study comparing the effects of sulindac 200 mg twice daily, naproxen 500 mg twice daily, and placebo on blood pressure. All patients were treated for hypertension with propranolol monotherapy. Blood pressures were back-titrated to achieve a baseline diastolic blood pressure of 90 to 100 mm Hg while taking naproxen. There were no significant differences in mean sitting or standing blood pressures among the patients receiving naproxen, sulindac, or placebo treatments. There was no change in pulse, weight, or any of the laboratory measurements at the end of each treatment phase. These results suggest that neither sulindac nor naproxen interferes with propranolol therapy for uncomplicated hypertension.
Schuna
A A
AA
William S. Middleton Veterans Administration Medical Center, Madison, Wisconsin.
Vejraska
B D
BD
Hiatt
J G
JG
Kochar
M
M
Day
R
R
Goodfriend
T L
TL
D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007192:Indenes / Q000627:therapeutic use*; D008875:Middle Aged; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D011188:Potassium / Q000097:blood; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D011897:Random Allocation; D012083:Renin / Q000097:blood; D012964:Sodium / Q000097:blood; D013467:Sulindac / Q000009:adverse effects / Q000627:therapeutic use*
D007192:Indenes; D013467:Sulindac; D009288:Naproxen; D012964:Sodium; D011433:Propranolol; D003404:Creatinine; D012083:Renin; D011188:Potassium